Sattva Sukun Lifecare approves name change and EGM for July 22

1 min read     Updated on 30 Jun 2026, 05:36 PM
scanx
Reviewed by
Jubin VScanX News Team
AI Summary

Sattva Sukun Lifecare Limited's board approved the regularization of Mr. Sachin Bhanubhai Manseta and Mr. Chirag Dedhia as directors and proposed changing the company name to Tavexia Lifecare Limited. The board also approved altering the Memorandum of Association to expand business activities and shifting the registered office within Mumbai effective July 1, 2026. An Extra-Ordinary General Meeting is scheduled for July 22, 2026, to seek shareholder approval for these resolutions.

powered bylight_fuzz_icon
43856426

*this image is generated using AI for illustrative purposes only.

Sattva Sukun Lifecare Limited has approved the regularization of two directors and a proposal to change its name to Tavexia Lifecare Limited, subject to shareholder approval. The board, meeting on June 30, 2026, also sanctioned the alteration of the Object Clause of the Memorandum of Association to include new business activities such as general trading, international consultancy, and research and development centres. An Extra-Ordinary General Meeting (EGM) is scheduled for July 22, 2026, to finalize these decisions.

Director Regularization

The board approved the regularization of Mr. Sachin Bhanubhai Manseta (DIN: 03471126) as a Non-Executive Independent Director and Mr. Chirag Dedhia (DIN: 08583331) as a Non-Executive Non-Independent Director. Both were initially appointed as Additional Directors on April 24, 2026. Their regularization is subject to shareholder approval, with tenures effective from July 22, 2026, for five years. Mr. Chirag Dedhia is liable to retire by rotation.

Name Change and MOA Alteration

Shareholders will vote on a special resolution to change the company name from Sattva Sukun Lifecare Limited to Tavexia Lifecare Limited. The board has also approved alternative names—Trumaxa Lifecare Limited, Trustarex Lifecare Limited, or Tradamex Life Care Limited—subject to availability and approval by the Central Registration Centre and Ministry of Corporate Affairs. The company seeks to alter Clause III(A) of the Memorandum of Association to carry on business as general merchants, international trade consultants, and to establish research and development centres.

Registered Office Shift

The board approved shifting the registered office within Mumbai to Plot No. 2B/1, Ground Floor, Kandivali Co-operative Industrial Estate Ltd., Hindustan Naka, Kandivali (West), effective from July 1, 2026. The company stated the move is for administrative convenience and will not affect business operations.

Key Meeting Details

Particulars Details
Meeting Date July 22, 2026
Meeting Time 2:00 P.M. IST
Mode Video Conferencing / Other Audio Visual Means
Remote E-Voting Start July 19, 2026, 9:00 a.m. IST
Remote E-Voting End July 21, 2026, 5:00 p.m. IST
Cut-off Date July 15, 2026

Mr. Brajesh Gupta, Practicing Company Secretary, has been appointed as the Scrutinizer to oversee the e-voting process. The results will be declared within two working days of the meeting's conclusion.

Historical Stock Returns for Sattva Sukun Lifecare

1 Day5 Days1 Month6 Months1 Year5 Years
+1.30%+2.63%+4.00%-4.88%-13.33%-76.00%

What strategic rationale is driving the shift from 'Sattva Sukun' to 'Tavexia', and how does the new name align with the expanded business objectives?

How will the inclusion of general trading and international consultancy impact the company's core revenue model and risk profile?

What specific R&D initiatives does the company plan to undertake following the alteration of the Memorandum of Association?

like18
dislike

Sattva Sukun submits audited FY26 results to BSE

1 min read     Updated on 08 Jun 2026, 02:25 PM
scanx
Reviewed by
Riya DScanX News Team
AI Summary

Sattva Sukun Lifecare Limited submitted newspaper clippings of its audited standalone and consolidated financial results for the quarter and year ended March 31, 2026, to BSE. The company reported a net profit of ₹16.52 lakh for FY26, reversing from a loss in the prior quarter. Total income for the year decreased to ₹423.70 lakh, while expenses rose to ₹420.78 lakh.

powered bylight_fuzz_icon
41246350

*this image is generated using AI for illustrative purposes only.

Sattva Sukun Lifecare Limited submitted newspaper clippings of its audited standalone and consolidated financial results for the quarter and year ended March 31, 2026, to BSE Limited. The results were published in Mumbai Lakshadweep (Marathi) and Active Times (English) in compliance with Regulation 47(l)(a) of the SEBI (LODR) Regulations, 2015. The company reported a net profit of ₹16.52 lakh for FY26, reversing from a loss of ₹56.97 lakh in the quarter ended March 31, 2026.

The Board approved the financial results at a meeting held on June 4, 2026, which was rescheduled from May 30, 2026, to complete the audit process. M/s. SSRV & Associates, the statutory auditors, issued an unmodified opinion on the financial statements. Total income from operations for the year stood at ₹423.70 lakh, a decrease from ₹566.69 lakh in the previous year. For the quarter, total income was ₹33.41 lakh compared to ₹131.51 lakh in the corresponding period of the previous year.

Financial Performance

The company reported a profit before tax of ₹2.92 lakh for FY26, significantly lower than ₹318.78 lakh in FY25. Total expenses for the year increased to ₹420.78 lakh from ₹247.91 lakh in the previous year. The basic earnings per share (EPS) for FY26 was ₹0.00, compared to ₹0.13 in the previous year.

Metric Q4FY26 (₹ in Lacs) Q4FY25 (₹ in Lacs) FY26 (₹ in Lacs) FY25 (₹ in Lacs)
Total Income 33.41 131.51 423.70 566.69
Total Expenses 109.32 40.63 420.78 247.91
Net Profit/Loss (56.97) 84.22 16.52 249.02
Basic EPS (0.01) 0.04 0.00 0.13

Rights Issue Utilization

During the financial year 2025-26, the company allotted 19,16,01,248 equity shares on a rights issue basis, raising ₹19.16 crore. The funds were utilized for working capital, business expansion, and investment in subsidiaries. The company confirmed there was no deviation in the use of funds raised.

Trading Window Closure

The trading window for designated persons and their immediate relatives remains closed. The window closed on April 01, 2026, and will reopen 48 hours after the conclusion of the Board Meeting, in accordance with SEBI (Prohibition of Insider Trading) Regulations, 2015.

Source: https://lodr-files.dhan.co/lodr-inputs/Company/INE280E01038/403ed9a6-2f51-487d-840a-2be9d23fcd23.pdf

Historical Stock Returns for Sattva Sukun Lifecare

1 Day5 Days1 Month6 Months1 Year5 Years
+1.30%+2.63%+4.00%-4.88%-13.33%-76.00%

What specific strategies will the company implement to reverse the decline in total income from operations?

How will the ₹19.16 crore raised from the rights issue specifically drive business expansion and improve future profitability?

What measures are being taken to control the significant surge in total expenses observed during FY26?

like19
dislike

More News on Sattva Sukun Lifecare

Must Read Next

Earnings

Corporate Actions

Stocks

1 Year Returns:-13.33%